Key Insights
The G-protein Coupled Receptors (GPCR) market, valued at $6.11 billion in 2025, is projected to experience robust growth, driven by a Compound Annual Growth Rate (CAGR) of 7.01% from 2025 to 2033. This expansion is fueled by several key factors. Firstly, the increasing prevalence of chronic diseases like cardiovascular disorders, neurological conditions, and cancer necessitates the development of novel therapeutic interventions targeting GPCRs. Advancements in assay technologies, including Calcium Level Detection Assays, Radioligand Binding Assays, and β-Arrestin Functional Assays, are enhancing research and drug discovery efforts, further bolstering market growth. The pharmaceutical and biotechnology industries are significantly investing in GPCR research, recognizing their crucial role in various physiological processes and their potential as drug targets. Moreover, the growing adoption of personalized medicine approaches is expected to create additional demand for sophisticated GPCR assays and related technologies. The market is segmented by assay type and application, with cardiovascular, central nervous system (CNS), and oncology applications dominating the market share.
G-protein Coupled Receptors Market Market Size (In Billion)
Geographical expansion is also a significant driver, with North America and Europe currently holding substantial market shares due to established healthcare infrastructure and robust research activities. However, the Asia-Pacific region is poised for rapid growth, fueled by increasing healthcare expenditure and a rising prevalence of target diseases. Competitive dynamics are shaped by the presence of both established players like Becton Dickinson, Promega, and Thermo Fisher Scientific, and emerging biotechnology companies focused on innovative GPCR-targeted therapies. While challenges remain, including the complexity of GPCR signaling pathways and the need for more efficient drug development strategies, the overall outlook for the GPCR market remains highly positive, indicating considerable growth opportunities throughout the forecast period. This growth will be influenced by the continued development of novel assay techniques, expanding research, and the introduction of innovative GPCR-targeted therapeutics.
G-protein Coupled Receptors Market Company Market Share
G-protein Coupled Receptors Market: A Comprehensive Report (2019-2033)
This comprehensive report provides an in-depth analysis of the G-protein Coupled Receptors (GPCR) market, offering valuable insights for stakeholders across the pharmaceutical, biotechnology, and research sectors. The report covers the period 2019-2033, with a focus on the forecast period 2025-2033 and a base year of 2025. Key market segments, leading players, and emerging trends are meticulously examined to deliver actionable intelligence for strategic decision-making. The total market size is projected to reach xx Million by 2033, exhibiting a CAGR of xx% during the forecast period.
G-protein Coupled Receptors Market Market Structure & Competitive Dynamics
The GPCR market exhibits a moderately consolidated structure, with several large players holding significant market share. The market is characterized by intense competition driven by innovation in assay technologies, expansion into new therapeutic areas, and strategic mergers and acquisitions (M&A). Regulatory frameworks governing drug development and approval significantly influence market dynamics. The presence of substitute technologies, particularly in specific assay types, necessitates continuous innovation to maintain competitive advantage. End-user trends, particularly in research and drug discovery, significantly impact demand.
- Market Concentration: The top 5 players account for approximately xx% of the global market share in 2025.
- Innovation Ecosystem: A vibrant ecosystem of academic research institutions, pharmaceutical companies, and biotechnology firms fuels continuous advancements in GPCR research and drug development.
- Regulatory Landscape: Stringent regulatory requirements for drug approval drive investment in robust clinical trials and data generation.
- Product Substitutes: Alternative technologies for drug screening and discovery pose a competitive challenge, particularly in specific assay types.
- M&A Activity: Significant M&A activity in recent years reflects the strategic importance of GPCRs in drug development, with total deal values exceeding xx Million in the last five years. Deals often focus on expanding product portfolios and technological capabilities.
- End-User Trends: Growth in research funding and drug discovery initiatives fuels increasing demand for GPCR-related products and services.
G-protein Coupled Receptors Market Industry Trends & Insights
The GPCR market is experiencing robust growth, driven by several key factors. The increasing prevalence of diseases treatable with GPCR-targeted drugs, coupled with technological advancements in assay development and high-throughput screening, are major growth catalysts. The rising adoption of advanced analytical techniques and the development of novel assay platforms enhance the efficiency and accuracy of GPCR research. Furthermore, growing collaborations between pharmaceutical companies and academic institutions accelerate the development pipeline. Competitive dynamics are characterized by a continuous race to develop more efficient and cost-effective GPCR assays and drugs. Market penetration of advanced assays is increasing, with a projected xx% market penetration by 2033. The market is projected to experience substantial growth, with a CAGR of xx% from 2025 to 2033.
Dominant Markets & Segments in G-protein Coupled Receptors Market
The North American region holds a dominant position in the global GPCR market due to significant investment in research and development, a robust pharmaceutical industry, and early adoption of advanced technologies. Within assay types, Radioligand Binding and GTPγS Functional Assays currently holds the largest market share, driven by its established use in drug discovery. In terms of applications, the Cardiovascular System segment dominates due to the high prevalence of cardiovascular diseases and the significant role of GPCRs in their pathophysiology. Oncology is also a rapidly growing segment.
- Key Drivers for North American Dominance:
- High funding for biomedical research
- Presence of major pharmaceutical companies
- Well-established regulatory framework
- Dominant Assay Type: Radioligand Binding and GTPγS Functional Assays
- Established methodology and wide applicability
- Relatively high throughput
- Dominant Application: Cardiovascular System
- Large patient population with cardiovascular diseases
- Significant role of GPCRs in cardiovascular regulation
G-protein Coupled Receptors Market Product Innovations
Recent innovations in GPCR research focus on developing more sensitive and specific assays, improving high-throughput screening capabilities, and exploring novel therapeutic targets. Advances in technologies such as label-free assays and advanced imaging techniques are enhancing the efficiency and accuracy of GPCR research. These innovations are driving the development of more effective and targeted therapeutics for a wider range of diseases, improving market fit and boosting the competitive landscape.
Report Segmentation & Scope
The report segments the GPCR market by assay type and application.
- Assay Type: Calcium Level Detection Assays, Radioligand Binding and GTPγS Functional Assays, cAMP Assays and cGMP Assays, β-Arrestin Functional Assays, Reporter Gene Assays, Other Assay Types. Each segment exhibits distinct growth trajectories and competitive dynamics. Radioligand Binding and GTPγS Functional Assays currently hold the largest market share.
- Application: Cardiovascular System, Central Nervous System (CNS), Oncology, Other Applications. The Cardiovascular System application dominates due to the high prevalence of related diseases and significant role of GPCRs. Oncology is experiencing rapid growth.
Key Drivers of G-protein Coupled Receptors Market Growth
Several factors drive the growth of the GPCR market. These include:
- Technological Advancements: Development of advanced assay technologies enabling faster and more efficient screening of potential drug candidates.
- Increased Prevalence of Diseases: The rising incidence of cardiovascular diseases, neurological disorders, and cancer fuels demand for GPCR-targeted therapies.
- Growing Research and Development Investments: Significant investments in pharmaceutical and biotechnology research are accelerating the development pipeline for GPCR-based drugs.
- Favorable Regulatory Environment: Supportive regulatory frameworks in key markets facilitate the approval and commercialization of novel GPCR-targeted therapies.
Challenges in the G-protein Coupled Receptors Market Sector
Despite significant growth potential, several challenges hinder the GPCR market. These include:
- High Development Costs: The cost of developing and obtaining regulatory approval for new GPCR-targeted drugs is substantial.
- Technical Challenges: GPCRs are notoriously difficult targets for drug development, leading to high attrition rates in clinical trials.
- Competition: Intense competition from existing and emerging players can restrict market penetration of new products.
Leading Players in the G-protein Coupled Receptors Market Market
- Becton Dickinson and Company
- Promega Corporation
- Merck KGaA
- Eurofins Scientific
- HD Biosciences Co Ltd
- BioInvenu Inc
- Abcam plc
- PerkinElmer Inc
- Thermo Fisher Scientific
- Enzo Biochem Inc (Enzo Life Sciences Inc)
- Danaher (Molecular Devices LLC)
- Addex Therapeutics
Key Developments in G-protein Coupled Receptors Market Sector
- April 2022: Ono Pharmaceutical Co., Ltd. signed a new collaboration agreement with Domain Therapeutics and Universite de Montreal to discover novel small molecules targeting G-Protein Coupled Receptors (GPCRs) in a metabolic disease area. This signals a growing interest in applying GPCR research to metabolic diseases.
- January 2022: Septerna, Inc., raised a Series A financing of USD 100 Million to expand the frontier of GPCR-Targeted medicines using the native Complex Platform. This significant investment highlights the substantial potential of GPCR-targeted therapies.
Strategic G-protein Coupled Receptors Market Market Outlook
The GPCR market is poised for significant growth in the coming years, driven by continued technological innovation, increased research funding, and the growing prevalence of target diseases. Strategic opportunities lie in developing novel assays, targeting under-researched GPCRs, and exploring new therapeutic applications. Partnerships and collaborations between pharmaceutical companies and research institutions will be crucial for accelerating drug development and market expansion. The market is expected to witness a considerable expansion in the next decade, presenting attractive opportunities for established and emerging players.
G-protein Coupled Receptors Market Segmentation
-
1. Assay Type
- 1.1. Calcium Level Detection Assays
- 1.2. Radioligand Binding and GTPγS Functional Assays
- 1.3. cAMP Assays and cGMP Assays
- 1.4. β-Arrestin Functional Assays
- 1.5. Reporter Gene Assays
- 1.6. Other Assay Types
-
2. Application
- 2.1. Cardiovascular System
- 2.2. Central Nervous System (CNS)
- 2.3. Oncology
- 2.4. Other Applications
G-protein Coupled Receptors Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
G-protein Coupled Receptors Market Regional Market Share
Geographic Coverage of G-protein Coupled Receptors Market
G-protein Coupled Receptors Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 7.01% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Growing Demand for GPCR Assays in Drug Discovery Studies; Wide Range Applications of GPCRs in the Treatment for Various Medical Conditions; Increasing Prevalence of Chronic Diseases
- 3.3. Market Restrains
- 3.3.1. Challenges with the Purification of GPCRs; Complexity of the GPCR Signalling System
- 3.4. Market Trends
- 3.4.1. Oncology by Application Segment is Estimated to Hold a Significant Share of the Market Over Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global G-protein Coupled Receptors Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Assay Type
- 5.1.1. Calcium Level Detection Assays
- 5.1.2. Radioligand Binding and GTPγS Functional Assays
- 5.1.3. cAMP Assays and cGMP Assays
- 5.1.4. β-Arrestin Functional Assays
- 5.1.5. Reporter Gene Assays
- 5.1.6. Other Assay Types
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Cardiovascular System
- 5.2.2. Central Nervous System (CNS)
- 5.2.3. Oncology
- 5.2.4. Other Applications
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Middle East and Africa
- 5.3.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Assay Type
- 6. North America G-protein Coupled Receptors Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Assay Type
- 6.1.1. Calcium Level Detection Assays
- 6.1.2. Radioligand Binding and GTPγS Functional Assays
- 6.1.3. cAMP Assays and cGMP Assays
- 6.1.4. β-Arrestin Functional Assays
- 6.1.5. Reporter Gene Assays
- 6.1.6. Other Assay Types
- 6.2. Market Analysis, Insights and Forecast - by Application
- 6.2.1. Cardiovascular System
- 6.2.2. Central Nervous System (CNS)
- 6.2.3. Oncology
- 6.2.4. Other Applications
- 6.1. Market Analysis, Insights and Forecast - by Assay Type
- 7. Europe G-protein Coupled Receptors Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Assay Type
- 7.1.1. Calcium Level Detection Assays
- 7.1.2. Radioligand Binding and GTPγS Functional Assays
- 7.1.3. cAMP Assays and cGMP Assays
- 7.1.4. β-Arrestin Functional Assays
- 7.1.5. Reporter Gene Assays
- 7.1.6. Other Assay Types
- 7.2. Market Analysis, Insights and Forecast - by Application
- 7.2.1. Cardiovascular System
- 7.2.2. Central Nervous System (CNS)
- 7.2.3. Oncology
- 7.2.4. Other Applications
- 7.1. Market Analysis, Insights and Forecast - by Assay Type
- 8. Asia Pacific G-protein Coupled Receptors Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Assay Type
- 8.1.1. Calcium Level Detection Assays
- 8.1.2. Radioligand Binding and GTPγS Functional Assays
- 8.1.3. cAMP Assays and cGMP Assays
- 8.1.4. β-Arrestin Functional Assays
- 8.1.5. Reporter Gene Assays
- 8.1.6. Other Assay Types
- 8.2. Market Analysis, Insights and Forecast - by Application
- 8.2.1. Cardiovascular System
- 8.2.2. Central Nervous System (CNS)
- 8.2.3. Oncology
- 8.2.4. Other Applications
- 8.1. Market Analysis, Insights and Forecast - by Assay Type
- 9. Middle East and Africa G-protein Coupled Receptors Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Assay Type
- 9.1.1. Calcium Level Detection Assays
- 9.1.2. Radioligand Binding and GTPγS Functional Assays
- 9.1.3. cAMP Assays and cGMP Assays
- 9.1.4. β-Arrestin Functional Assays
- 9.1.5. Reporter Gene Assays
- 9.1.6. Other Assay Types
- 9.2. Market Analysis, Insights and Forecast - by Application
- 9.2.1. Cardiovascular System
- 9.2.2. Central Nervous System (CNS)
- 9.2.3. Oncology
- 9.2.4. Other Applications
- 9.1. Market Analysis, Insights and Forecast - by Assay Type
- 10. South America G-protein Coupled Receptors Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Assay Type
- 10.1.1. Calcium Level Detection Assays
- 10.1.2. Radioligand Binding and GTPγS Functional Assays
- 10.1.3. cAMP Assays and cGMP Assays
- 10.1.4. β-Arrestin Functional Assays
- 10.1.5. Reporter Gene Assays
- 10.1.6. Other Assay Types
- 10.2. Market Analysis, Insights and Forecast - by Application
- 10.2.1. Cardiovascular System
- 10.2.2. Central Nervous System (CNS)
- 10.2.3. Oncology
- 10.2.4. Other Applications
- 10.1. Market Analysis, Insights and Forecast - by Assay Type
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Becton Dickinson and Company
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Promega Corporation
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Merck KGaA
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Eurofins Scientific
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 HD Biosciences Co Ltd
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 BioInvenu Inc
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Abcam plc
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 PerkinElmer Inc
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Thermo Fisher Scientific
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Enzo Biochem Inc (Enzo Life Sciences Inc )
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Danaher (Molecular Devices LLC)
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Addex Therapeutics
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Becton Dickinson and Company
List of Figures
- Figure 1: Global G-protein Coupled Receptors Market Revenue Breakdown (Million, %) by Region 2025 & 2033
- Figure 2: North America G-protein Coupled Receptors Market Revenue (Million), by Assay Type 2025 & 2033
- Figure 3: North America G-protein Coupled Receptors Market Revenue Share (%), by Assay Type 2025 & 2033
- Figure 4: North America G-protein Coupled Receptors Market Revenue (Million), by Application 2025 & 2033
- Figure 5: North America G-protein Coupled Receptors Market Revenue Share (%), by Application 2025 & 2033
- Figure 6: North America G-protein Coupled Receptors Market Revenue (Million), by Country 2025 & 2033
- Figure 7: North America G-protein Coupled Receptors Market Revenue Share (%), by Country 2025 & 2033
- Figure 8: Europe G-protein Coupled Receptors Market Revenue (Million), by Assay Type 2025 & 2033
- Figure 9: Europe G-protein Coupled Receptors Market Revenue Share (%), by Assay Type 2025 & 2033
- Figure 10: Europe G-protein Coupled Receptors Market Revenue (Million), by Application 2025 & 2033
- Figure 11: Europe G-protein Coupled Receptors Market Revenue Share (%), by Application 2025 & 2033
- Figure 12: Europe G-protein Coupled Receptors Market Revenue (Million), by Country 2025 & 2033
- Figure 13: Europe G-protein Coupled Receptors Market Revenue Share (%), by Country 2025 & 2033
- Figure 14: Asia Pacific G-protein Coupled Receptors Market Revenue (Million), by Assay Type 2025 & 2033
- Figure 15: Asia Pacific G-protein Coupled Receptors Market Revenue Share (%), by Assay Type 2025 & 2033
- Figure 16: Asia Pacific G-protein Coupled Receptors Market Revenue (Million), by Application 2025 & 2033
- Figure 17: Asia Pacific G-protein Coupled Receptors Market Revenue Share (%), by Application 2025 & 2033
- Figure 18: Asia Pacific G-protein Coupled Receptors Market Revenue (Million), by Country 2025 & 2033
- Figure 19: Asia Pacific G-protein Coupled Receptors Market Revenue Share (%), by Country 2025 & 2033
- Figure 20: Middle East and Africa G-protein Coupled Receptors Market Revenue (Million), by Assay Type 2025 & 2033
- Figure 21: Middle East and Africa G-protein Coupled Receptors Market Revenue Share (%), by Assay Type 2025 & 2033
- Figure 22: Middle East and Africa G-protein Coupled Receptors Market Revenue (Million), by Application 2025 & 2033
- Figure 23: Middle East and Africa G-protein Coupled Receptors Market Revenue Share (%), by Application 2025 & 2033
- Figure 24: Middle East and Africa G-protein Coupled Receptors Market Revenue (Million), by Country 2025 & 2033
- Figure 25: Middle East and Africa G-protein Coupled Receptors Market Revenue Share (%), by Country 2025 & 2033
- Figure 26: South America G-protein Coupled Receptors Market Revenue (Million), by Assay Type 2025 & 2033
- Figure 27: South America G-protein Coupled Receptors Market Revenue Share (%), by Assay Type 2025 & 2033
- Figure 28: South America G-protein Coupled Receptors Market Revenue (Million), by Application 2025 & 2033
- Figure 29: South America G-protein Coupled Receptors Market Revenue Share (%), by Application 2025 & 2033
- Figure 30: South America G-protein Coupled Receptors Market Revenue (Million), by Country 2025 & 2033
- Figure 31: South America G-protein Coupled Receptors Market Revenue Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Assay Type 2020 & 2033
- Table 2: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Application 2020 & 2033
- Table 3: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Region 2020 & 2033
- Table 4: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Assay Type 2020 & 2033
- Table 5: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Application 2020 & 2033
- Table 6: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Country 2020 & 2033
- Table 7: United States G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 8: Canada G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 9: Mexico G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 10: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Assay Type 2020 & 2033
- Table 11: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Application 2020 & 2033
- Table 12: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Country 2020 & 2033
- Table 13: Germany G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 14: United Kingdom G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 15: France G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 16: Italy G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 17: Spain G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 18: Rest of Europe G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 19: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Assay Type 2020 & 2033
- Table 20: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Application 2020 & 2033
- Table 21: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Country 2020 & 2033
- Table 22: China G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 23: Japan G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 24: India G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 25: Australia G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 26: South Korea G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 27: Rest of Asia Pacific G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 28: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Assay Type 2020 & 2033
- Table 29: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Application 2020 & 2033
- Table 30: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Country 2020 & 2033
- Table 31: GCC G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 32: South Africa G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 33: Rest of Middle East and Africa G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 34: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Assay Type 2020 & 2033
- Table 35: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Application 2020 & 2033
- Table 36: Global G-protein Coupled Receptors Market Revenue Million Forecast, by Country 2020 & 2033
- Table 37: Brazil G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 38: Argentina G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
- Table 39: Rest of South America G-protein Coupled Receptors Market Revenue (Million) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the G-protein Coupled Receptors Market?
The projected CAGR is approximately 7.01%.
2. Which companies are prominent players in the G-protein Coupled Receptors Market?
Key companies in the market include Becton Dickinson and Company, Promega Corporation, Merck KGaA, Eurofins Scientific, HD Biosciences Co Ltd, BioInvenu Inc, Abcam plc, PerkinElmer Inc, Thermo Fisher Scientific, Enzo Biochem Inc (Enzo Life Sciences Inc ), Danaher (Molecular Devices LLC), Addex Therapeutics.
3. What are the main segments of the G-protein Coupled Receptors Market?
The market segments include Assay Type, Application.
4. Can you provide details about the market size?
The market size is estimated to be USD 6.11 Million as of 2022.
5. What are some drivers contributing to market growth?
Growing Demand for GPCR Assays in Drug Discovery Studies; Wide Range Applications of GPCRs in the Treatment for Various Medical Conditions; Increasing Prevalence of Chronic Diseases.
6. What are the notable trends driving market growth?
Oncology by Application Segment is Estimated to Hold a Significant Share of the Market Over Forecast Period.
7. Are there any restraints impacting market growth?
Challenges with the Purification of GPCRs; Complexity of the GPCR Signalling System.
8. Can you provide examples of recent developments in the market?
April 2022: Ono Pharmaceutical Co., Ltd. signed a new collaboration agreement with Domain Therapeutics and Universite de Montreal to discover novel small molecules targeting G-Protein Coupled Receptors (GPCRs) in a metabolic disease area.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "G-protein Coupled Receptors Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the G-protein Coupled Receptors Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the G-protein Coupled Receptors Market?
To stay informed about further developments, trends, and reports in the G-protein Coupled Receptors Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence